Fresh analysis indicates that people who discontinue new GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt traditional lifestyle plans.
Published data in a major medical journal shows that while obese people often shed a large proportion of their body weight while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"People using these medications should be aware of the danger of rapid rebound weight gain when the medication concludes," warns expert Dr. Susan Jebb.
Such speed of regain suggests a return to starting weight within about one and a half years.
Analyzing Therapies
The research, which examined dozens of trials involving over 9,000 of patients, contrasted the results of these new drugs with conventional dieting.
Scientists point out that individuals who shed pounds through dieting generally have a slower weight regain—perhaps 0.1 kg a month—after stopping.
The Reason for the Rapid Regain
Nutrition scientists suggest the way of the injections explains the amplified weight return.
These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is uncontrolled, making binge eating a significant risk."
A Lifelong Condition?
Health authorities advise the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, given the significant potential of relapse, the treatment should be considered life-long.
This view is supported by drug manufacturers, who say that the results "underscore the persistent nature of excess weight," similar to managing conditions like diabetes.
User Experiences
People who have discontinued the jabs describe a sudden return of hunger.
"I experienced a switch that goes on and I was suddenly extremely hungry," recalled an individual.
The struggle is worsened if users have not developed permanent lifestyle or habit changes during therapy.
Growing Adoption
Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is higher among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Finally, clinicians stress that while the jabs are effective agents for weight loss, they are not a standalone fix and lasting health benefits relies on combined lifestyle changes.
